PerkinElmer launches free COVID-19 data dashboards

By The Science Advisory Board staff writers

PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.

PerkinElmer's COVID-19 drug compound dashboard allows scientists to narrow down the 1.6 million drug compounds that are publicly available by querying a curated chemical substance dataset and related activity data.

Its COVID-19 clinical trial dashboard collects data from sources like the U.S. National Library of Medicine's It provides access to trial status, drug compounds being studied, and use of live or dead virus, antibody, antiviral, or DNA-based vaccine approaches.

Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?